|
NIBM Update 06-17-2002 (Number 9) |
|
- Cover -
Throw 'em all in jail
- Page 2 -
Changes coming to NIBM Newsletter
- Page 3 -
Macro Market Notes & Analysis
- Page 4 -
NIBM Model Portfolio Updates
-
(GNTA, NABI, DNDN, IDBE)
- Page 5 -
News Briefs
- Procrit
counterfeit troubles
- Millenium
initiated Phase III in multiple myeloma
- FDA
Commissioner on the way?
-
Academics beat Genentech
-
IDEC Pharma halts MAb trial on safety concerns
-
BMY's woes deepen as AGs gang up
-
PDLI's Zamyl flunks AML Phase III test
|
 |
|
| NIBM Updates are
available only to subscribers. In each update we analyze current market trends inside and
outside the biotech market sector. We also provide updates on the companies that appear in
our monthly NIBM Newsletter. Click on the box above to become a
subscriber today! |
Subscriber direct access |
|
| |
|
|
 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
